This proposed mechanism is supported by our findings that both plasma leptin and hypothalamic IL-1β expression were positively correlated with hypothalamic expression of GFAP, and IL-1β expression was associated with metabolic outcomes in AD females only. Here, GFAP is linked to Alzheimer disease.